Rapidly progressive glomerulonephritis

62,606views

Rapidly progressive glomerulonephritis

Dr. Andrews

Dr. Andrews

Cell cycle
Oncogenes and tumor suppressor genes
Non-Hodgkin lymphoma
Hodgkin lymphoma
DiGeorge syndrome
Hydronephrosis
Acute pyelonephritis
Chronic pyelonephritis
Vesicoureteral reflux
Bladder exstrophy
BK virus (Hemorrhagic cystitis)
Non-urothelial bladder cancers
Development of the umbilical cord
Development of the fetal membranes
Dizziness and vertigo: Clinical
Reactive arthritis
Klinefelter syndrome
Testicular tumors: Pathology review
DNA alkylating medications
Androgens and antiandrogens
PDE5 inhibitors
Adrenergic antagonists: Alpha blockers
Estrogens and antiestrogens
Progestins and antiprogestins
Aromatase inhibitors
Uterine stimulants and relaxants
Anatomy of the pelvic cavity
Pelvic inflammatory disease
Vulvar cancer: Clinical
Vaginal and vulvar disorders: Pathology review
Chlamydia trachomatis
Papulosquamous skin disorders: Clinical
Transitional cell carcinoma
Human papillomavirus
Paget disease of the breast
Vascular tumors
Development of the digestive system and body cavities
Nephroblastoma (Wilms tumor)
Development of the renal system
Antimetabolites for cancer treatment
Hypothyroidism: Pathology review
Hashimoto thyroiditis
Hyperthyroidism: Pathology review
Thyroid cancer
Thyroid nodules and thyroid cancer: Pathology review
Riedel thyroiditis
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Adrenal masses and tumors: Clinical
Sheehan syndrome
Cervical cancer
Ovarian cyst
Pheochromocytoma
Multiple endocrine neoplasia: Pathology review
Carcinoid syndrome
Vaginal cancer: Clinical
Acromegaly
Multiple endocrine neoplasia
Parathyroid hormone
Cystic fibrosis
Preeclampsia & eclampsia
Necrotizing enterocolitis
Neonatal respiratory distress syndrome
Galactosemia
Phenylketonuria (NORD)
WAGR syndrome
Focal segmental glomerulosclerosis (NORD)
Nephrotic syndromes: Pathology review
Membranoproliferative glomerulonephritis
Nephritic syndromes: Pathology review
IgA nephropathy (NORD)
Diabetic nephropathy
Membranous nephropathy
Minimal change disease
Ribonucleotide reductase inhibitors
Alport syndrome
Rapidly progressive glomerulonephritis
Goodpasture syndrome
Neurogenic bladder
Polycystic ovary syndrome
Endometrial hyperplasia
Renal system anatomy and physiology
Medullary cystic kidney disease
Krukenberg tumor
Polycystic kidney disease
Multicystic dysplastic kidney
Medullary sponge kidney
Horseshoe kidney
The role of the kidney in acid-base balance
Pancreatic cancer
Pancreatic neuroendocrine neoplasms
Acute pancreatitis
Chronic pancreatitis
Microtubule inhibitors
Bordetella pertussis (Whooping cough)
Topoisomerase inhibitors
Breast cancer
Prostate disorders and cancer: Pathology review
Antidiuretic hormone
Estrogen and progesterone
Li-Fraumeni syndrome
Renal agenesis
Gene regulation
Familial adenomatous polyposis
Mendelian genetics and punnett squares
Uterine fibroid
Respiratory acidosis
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Antituberculosis medications
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
Peutz-Jeghers syndrome
Anatomy of the perineum

Transcript

Watch video only

Content Reviewers

Crescentic glomerulonephritis, which is sometimes called rapidly progressive glomerulonephritis, is a type of nephritic syndrome, meaning it involves inflammation of the kidney’s glomeruli.

This inflammation ultimately causes a proliferation of cells in the Bowman’s space, which forms a crescent shape and this change leads to renal failure relatively quickly—within weeks to months.

The development of crescents in Bowman’s space can happen in several ways.

In some cases it’s the idiopathic, meaning there’s no identifiable cause.

When the cause is identifiable, though, it can be split into several types.

Type I is caused by anti-glomerular basement membrane, or GBM, antibodies, antibodies that target the GBM.

Type I is associated with Goodpasture syndrome, which also involves pulmonary hemorrhages.

Type II is immune-complex-mediated, meaning caused by immune complexes, composed of antigens and antibodies.

This might be the case with poststreptococcal glomerulonephritis, systemic lupus erythematosus, IgA nephropathy, and Henoch-Schonlein purpura.

And finally type III is known as pauci-immune, meaning little or no anti-GBM antibodies or immune-complex deposits.

In these cases, often anti-neutrophilic cytoplasmic antibodies or ANCAs are in the blood, which are autoantibodies against the body’s own neutrophils.

Furthermore, you can break it down into the type of ANCA. C-ANCAs, or cytoplasmic ANCAs, are associated with Wegener granulomatosis.

P-ANCAs or perinuclear ANCAs on the other hand are associated with microscopic polyangiitis and Churg-Strauss syndrome, the latter of which can be distinguished by having granulomatous inflammation, which is when immune cells attempt to wall off a substance perceived as foreign, asthma, and eosinophilia

Whatever the underlying cause is, the common feature is severe glomerular injury and the development of a crescent shape.

Typically, as a result of cell-mediated immunity as well as macrophage involvement, the glomerular basement membrane breaks.

Key Takeaways

Rapidly progressive glomerulonephritis (RPGN) is a type of kidney disease characterized by a rapid loss of renal function, with characteristic glomerular crescent-shaped scars seen on renal biopsies. It is caused by inflammation and damage to the glomeruli, which can result from conditions like infections, immune disorders, and vasculitis.

Symptoms of RPGN can include blood in the urine, swelling in the legs and face, high blood pressure, and decreased urine output. The condition can progress rapidly, leading to kidney failure if left untreated. Treatment options may include immunosuppressive drugs to reduce inflammation, as well as a specific treatment for the underlying cause of the condition. If the renal failure becomes irreversible, dialysis or a kidney transplant are required.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "What is new in the management of rapidly progressive glomerulonephritis?" Clinical Kidney Journal (2015)
  6. "ANCA Glomerulonephritis and Vasculitis" Clinical Journal of the American Society of Nephrology (2017)
  7. "Incidence and outcome of pauci‐immune rapidly progressive glomerulonephritis in Wessex, UK: a 10‐year retrospective study" Nephrology Dialysis Transplantation (2000)